@[email protected] to [email protected]English • 1 year agoSemaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabeteswww.nejm.orgmessage-square3fedilinkarrow-up124arrow-down10
arrow-up124arrow-down1external-linkSemaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabeteswww.nejm.org@[email protected] to [email protected]English • 1 year agomessage-square3fedilink
minus-square😈MedicPig🐷BabySaver😈link1•1 year agoYeah, I haven’t heard any “good” stories. It’s definitely one of those treatments might be worse than the illness.
Yeah, I haven’t heard any “good” stories. It’s definitely one of those treatments might be worse than the illness.